Canagliflozin reduces oral loop diuretic intensification in patients with type 2 diabetes: A participant‐level pooled analysis of the CANVAS and CREDENCE trials.
Saved in:
| Title: | Canagliflozin reduces oral loop diuretic intensification in patients with type 2 diabetes: A participant‐level pooled analysis of the CANVAS and CREDENCE trials. |
|---|---|
| Authors: | Chatur, Safia1 (AUTHOR), Vaduganathan, Muthiah1 (AUTHOR), Fletcher, Robert A.2 (AUTHOR), Perkovic, Vlado2 (AUTHOR), Heerspink, Hiddo3 (AUTHOR), Arnott, Clare2,4 (AUTHOR), Pollock, Carol5 (AUTHOR), Mahaffey, Kenneth W.6 (AUTHOR), Neal, Bruce2,7 (AUTHOR), Jardine, Meg8,9 (AUTHOR), Solomon, Scott D.1 (AUTHOR), Neuen, Brendon L.2,10 (AUTHOR) bneuen@georgeinstitute.org.au |
| Source: | European Journal of Heart Failure. Jun2025, Vol. 27 Issue 6, p994-1002. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
